Evidence map›Paper›PMID 41169312›Full record

ArticleJTCVS open2025

Accuracy of DOTATATE-positron emission tomography for preoperative nodal staging of carcinoid tumors of the lung.

Lillian L Tsai, Sidharth Bommakanti, Sharmila Sridharan, Nathaniel J Myall, Brandon A Guenthart, Douglas Z Liou, Natalie S Lui, Leah M Backhus, Mark F Berry, Joseph B Shrager and 1 more

Abstract read
In one paragraph

Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lillian L TsaiDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Sidharth BommakantiDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Sharmila SridharanDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Nathaniel J MyallDivision of Medical Oncology, Department of Medicine, Stanford University Medical Center, Stanford, Calif.
Brandon A GuenthartDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Douglas Z LiouDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Natalie S LuiDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Leah M BackhusDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Mark F BerryDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Joseph B ShragerDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.
Irmina A ElliottDepartment of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, Calif.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: DOTATATE-positron emission tomography (PET) scans use a radiotracer that binds somatostatin receptor 2 on neuroendocrine cells to identify carcinoid tumors. Use of DOTATATE-PET during preoperative evaluation of lung carcinoids is increasing, but the accuracy of DOTATATE-PET in nodal staging of pulmonary carcinoids is unknown. Methods: We reviewed patients with lung carcinoids undergoing DOTATATE-PET before surgical resection between November 2013 and 2023. Exclusions included non-avid primary tumors on DOTATATE-PET or absent pathologic lymph node assessment. Using surgical pathology as the gold standard, we assessed concordance between DOTATATE-PET-based clinical stage and postoperative pathologic stage. Sensitivity, specificity, negative predictive value, and positive predictive value were calculated, with χ Results: Among 58 patients undergoing resection of lung carcinoid tumors (48 typical, 10 atypical carcinoids), 15 (25.8%) had pathologic nodal involvement, but DOTATATE-PET detected only 3. For the 43 patients who were pathologic node-negative, DOTATATE-PET was negative in 42. This yielded 42 true negatives, 3 true positives, 12 false negatives, and 1 false positive, with sensitivity of 20%, specificity 97.7%, negative predictive value 77.8%, positive predictive value 75%, and overall accuracy of 77.6%. Larger tumor size was significantly associated with inaccurate DOTATATE-PET ( Conclusions: DOTATATE-PET has poor sensitivity for nodal disease in patients with pulmonary carcinoid tumors. Thorough pathologic lymph node evaluation is necessary regardless of DOTATATE-PET results when resecting carcinoid tumors. Given that primary surgery is indicated even if it were known there were positive lymph nodes, the utility of a DOTATATE-PET is likely limited.

Indexed as

DOTATATE-PETlymph node diseasepulmonary carcinoidsensitivityspecificity

Identifiers

PMID41169312
PMCPMC12570576

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.